A federal judge in Chicago heard legal arguments on Tuesday about whether to stop the Illinois End‑of‑Life Options for Terminally Ill Patients Act from taking effect as planned on Saturday, Sept. 12, 2026.
The legislation, commonly referred to as “medical aid in dying,” allows adults who have been diagnosed with a terminal illness to obtain medication that can end their lives. Under the law, eligible patients would be able to request the medication through a regulated process involving physicians and state oversight.
The hearing focused on the request to block the law before its scheduled launch. Plaintiffs argued that the statute should not be implemented on the upcoming Saturday, while representatives of the Illinois state government defended the law’s readiness and its compliance with existing statutes.
If the judge grants a temporary injunction, the law’s activation on Sept. 12 would be paused, delaying the start of the medical aid‑in‑dying program. Conversely, a decision against the injunction would allow the law to proceed as scheduled, permitting terminally ill patients to access the new option at the end of the week.
The case underscores the legal scrutiny that new end‑of‑life policies can attract, especially when they involve the administration of life‑ending medication. The federal court’s ruling is expected to be issued before the law’s intended commencement date, determining whether Illinois will move forward with the program on the planned timeline.
The outcome will affect how the state implements the medical aid in dying framework and will set a precedent for how similar legislation may be contested in federal courts across the country.